Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar Jivy2008 (95.56) Submitted: 3/17/2009 5:53:51 PM : Outperform Start Price: $13.37 MYL Score: -11.00

Beating the S&P right now!

Featured Broker Partners


Advertisement